SHANGHAI, May 25, 2023 /PRNewswire/ — Dizal (688192.SH) today announced that data from its oncology portfolio will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, 2023 in Chicago. The data which include updated analyses of Dizal’s two leading assets – sunvozertinib (a selective EGFR TKI targeting a wide … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Regenerative Medicine Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The regenerative medicine market is estimated to be valued at US$19.322 billion in 2020. Companies Mentioned Novartis Amgen Bluebird Bio GSK plc. Shenzhen Sibiono Genetech Anterogen CO., LTD. Chiesi Farmaceutici S.p.a. Jcr Pharmaceuticals … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Industrial Cleaning Market – Forecasts from 2023 to 2028” report has been added to ResearchAndMarkets.com’s offering. The global industrial cleaning market is anticipated to expand at a compound annual growth rate of 4.84% during the projected period, from a market value of US$49.684 billion in 2021 to US$69.176 billion … Read more
SAN FRANCISCO, May 25, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be a sponsor and exhibitor at the 2023 BIO International Convention in Boston, MA, June 5-8, 2023. The conference will offer a range of valuable opportunities, including one-on-one partnering for business growth, networking events to … Read more
SAN FRANCISCO, May 25, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Chief Financial Officer (CFO) Yafei (Roxi) Wen is resigning to pursue other opportunities, effective June 30, 2023. The Company has initiated a search for a new CFO. Ms. Wen will continue in her role through the end of the second … Read more
Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more
CIUDAD DE MEXICO, 25 de mayo de 2023 /PRNewswire/ — Se dio a conocer la llegada a México del Método Abrahamson, creado en Israel. Al respecto, Arie Reboot, explica que dicho sistema de salud es el único tratamiento energético que ha ayudado a las personas a liberarse de adicciones, así como restablecer la vitalidad y … Read more
Elucidated molecular mechanism behind safety and efficacy of Bersiporocin Bersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary Fibrosis SEOUL, South Korea, May 25, 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for … Read more
31% week-16 overall response rate and 9.6-month median progression-free survival with pelareorep plus paclitaxel vs. 20% and 6.4 months with paclitaxel alone as of Oct. 2022 ASCO abstract cut-off date Updated data from May 2023 cut-off date will be presented in an oral presentation on June 3, 2023 Oncolytics to advance to registrational study of pelareorep-paclitaxel … Read more
LOS ANGELES, May 25, 2023 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced poster presentations at the 2023 ASCO Annual Meeting taking place June 2-6, 2023, in Chicago, IL. The abstracts associated with the … Read more